Tasly Pharmaceutical Group Co (SHSE:600535) ROCE % : 2.24% (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tasly Pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 2.24%.

Tasly Pharmaceutical Group Co ROCE % Historical Data

The historical data trend for Tasly Pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tasly Pharmaceutical Group Co ROCE % Chart

Tasly Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

11.97

19.68

-0.71

9.09

8.38

Tasly Pharmaceutical Group Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															0.90	11.16	12.10	6.17	2.24

Tasly Pharmaceutical Group Co ROCE % Calculation

Tasly Pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	1129.972	/	( ( (16714.285 - 2369.556)	+	(14976.295 - 2349.688) )	/ 2 )
	=	1129.972	/	( (14344.729	+	12626.607)	/ 2 )
	=	1129.972	/	13485.668
	=	8.38 %

Tasly Pharmaceutical Group Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	292.764	/	( ( (16834.745 - 3360.867)	+	(14976.295 - 2349.688) )	/ 2 )
	=	292.764	/	( ( 13473.878	+	12626.607 )	/ 2 )
	=	292.764	/	13050.2425
	=	2.24 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Tasly Pharmaceutical Group Co (SHSE:600535) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tasly Pharmaceutical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tasly Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410

Website

http://www.tasly.com

Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.

Executives

Wu Nai Feng

Director

Tasly Pharmaceutical Group Co Headlines

No Headlines